Patent · US Active

Material and methods for treating or preventing HER-3 associated diseases

US9101760B2 · kind B2 · utility

6Cited by

42References

36Claims

0Family size

Assignees

U3 Pharma GmbH · DE
AMGEN INC. · US

Inventors

Thore Hettmann · Birkenfeld, DE
Daniel J. Freeman · Newbury Park, US
Robert Radinsky · Thousand Oaks, US

Key dates

Filing date	Nov 12, 2010
Grant date	Aug 11, 2015
Priority date	—
Expiry date	Aug 17, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are materials and methods for treating subjects having a HER-3 associated disease, by administering a first agent that binds to HER-3, in combination with a second agent that binds and/or inhibits another member of the HER family. The first and the second agent may be a biologic, such as an antigen-binding protein, or a small molecular tyrosine kinase inhibitor, for example.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.